Vident Investment Advisory’s Novartis NVS Stock Holding History

Vident Investment Advisory’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,277	Closed	-$936K	–	701
2023 Q2	$936K	Buy	9,277 +1,494	+19%	+$149K	0.03%	496
2023 Q1	$716K	Buy	7,783 +1,000	+15%	+$87.3K	0.02%	636
2022 Q4	$615K	Buy	+6,783	New	+$571K	0.02%	642
2022 Q3	–	Sell	-2,448	Closed	-$208K	–	1252
2022 Q2	$208K	Buy	+2,448	New	+$215K	0.01%	1125
2018 Q4	–	Sell	-34,592	Closed	-$2.67M	–	879
2018 Q3	$2.67M	Sell	34,592 -2,419	-7%	-$179K	0.1%	268
2018 Q2	$2.5M	Buy	37,011 +13,685	+59%	+$944K	0.1%	278
2018 Q1	$1.7M	Buy	23,326 +6,830	+41%	+$520K	0.07%	331
2017 Q4	$1.24M	Buy	16,496 +417	+3%	+$31.5K	0.06%	344
2017 Q3	$1.24M	Buy	16,079 +486	+3%	+$36.7K	0.07%	340
2017 Q2	$1.17M	Buy	15,593 +1,691	+12%	+$120K	0.1%	307
2017 Q1	$925K	Buy	13,902 +2,223	+19%	+$148K	0.09%	311
2016 Q4	$762K	Buy	11,679 +1,848	+19%	+$120K	0.09%	301
2016 Q3	$696K	Sell	9,831 -49	-0.5%	-$3.57K	0.09%	317
2016 Q2	$730K	Sell	9,880 -11,168	-53%	-$772K	0.1%	310
2016 Q1	$1.37K	Buy	21,048 +10,996	+109%	+$748K	0.08%	341
2015 Q4	$775K	Buy	+10,052	New	+$799K	0.1%	337
2015 Q3	–	Sell	-20,300	Closed	-$1.79M	–	1117
2015 Q2	$1.79M	Buy	20,300 +4,869	+32%	+$447K	0.24%	110
2015 Q1	$1.36M	Buy	+15,431	New	+$1.37M	0.27%	79

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vident Investment Advisory's NVS Position: Q3 2023 in Review

Vident Investment Advisory sold out of Novartis (NVS) in Q3 2023, closing a stake of 9,277 shares — an estimated $936K sold.

Vident Investment Advisory first reported a position in NVS in Q1 2015 and held it in 18 quarters. The position peaked at $2.67M in Q3 2018. 1,223 funds tracked by Wall St. Rank hold NVS as of Q3 2023.

Vident Investment Advisory reported no remaining Novartis position as of Q3 2023 after selling out during the quarter.
Vident Investment Advisory sold 9,277 Novartis shares in Q3 2023, an estimated $936K.
Vident Investment Advisory first reported a position in Novartis in Q1 2015 and held it in 18 quarters.
Vident Investment Advisory's Novartis position peaked at $2.67M in Q3 2018.
1,223 funds tracked by Wall St. Rank held Novartis as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.